Latest News & Features
Asia
India’s Patent Office has revoked pharmaceutical company Sugen and licensee Pfizer’s patent for the cancer drug Sutent, agreeing with Indian drugs maker Cipla that it lacks inventive step. 14 February 2013
Americas
A US judge has declared pharmaceutical company Bristol-Myers Squibb’s patent covering its hepatitis B treatment Baraclude obvious and invalid. 14 February 2013
Americas
The Mexican Senate has published a bill which, if adopted, will reduce the life term of medicine patents in Mexico by up to one year. 1 February 2013
Asia-Pacific
The Federal Court in Australia has ruled in Cancer Voices Australia v. Myriad Genetics that isolated genetic material is patentable in Australia. Karen Sinclair explains the relevant issues. 1 February 2013
Asia
Sugen’s patent for anti-cancer drug sunitinib has been revoked by the Indian Patent Office. Ranjna Mehta-Dutt and Swarup Kumar at Remfry & Sagar explain the details of the matter. 1 February 2013
Big Pharma
It seems an unlikely place for innovation, but Lille and its surroundings play host to a burgeoning life sciences industry. LSIPR visited to find out more. 1 February 2013
Asia
India’s patent office has released comments submitted in response to draft examination guidelines for biotechnology patents published in December 2012. 31 January 2013
Americas
Canadian pharmaceutical firms Nuvo Research and Apotex have agreed a patent settlement allowing Apotex to launch a generic version of Nuvo’s arthritis treatment PENNSAID in the US. 31 January 2013
Americas
The University of Wisconsin’s alumni research foundation is suing Florida-based Virtus Pharmaceuticals for selling a calcium supplement it claims knowingly breaches one of its patents. 17 December 2012
Americas
The latest rulings in the controversial legal battle over breast cancer gene patents seem to have found two out of three issues in defendant Myriad Genetics’ favour, but legal counsel Ben Jackson isn’t too excited by the implications. 1 December 2012